Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
Stock Snapshot
With a market cap of 220.35B, Novo Nordisk(NVO) trades at $49.36. The stock has a price-to-earnings ratio of 14.17 and currently yields dividends of 2.5%.
On 2025-11-29, Novo Nordisk(NVO) stock moved within a range of $48.35 to $49.72. With shares now at $49.36, the stock is trading +2.1% above its intraday low and -0.7% below the session's peak.
Trading activity shows a volume of 15.48M, compared to an average daily volume of 23.14M.
Over the past 52 weeks, Novo Nordisk(NVO) stock has traded between a high of $112.52 and a low of $43.08.
Over the past 52 weeks, Novo Nordisk(NVO) stock has traded between a high of $112.52 and a low of $43.08.
NVO News
Below is Validea's guru fundamental report for NOVO NORDISK A/S (ADR) (NVO). Of the 22 guru strategies we follow, NVO rates highest using our Patient Investor m...
Wondering if Novo Nordisk is priced fairly, or if there could be a value play just waiting to be found? Let’s take a closer look at what’s been happening with t...
Investors will want to see these key developments concerning Novo Nordisk's pipeline of new treatments. The company revealed critical information that investor...
Analyst ratings
55%
of 31 ratingsMore NVO News
Novo Nordisk NVO and Pfizer PFE are pharmaceutical giants based in Denmark and the United States, respectively, with strong leadership positions in distinct the...
Novo Nordisk NVO announced that it has submitted a regulatory filing seeking label expansion for a higher dose of its blockbuster obesity drug, Wegovy (injectab...
The mid-cap biotech could become a notable player in the industry's hottest therapeutic area. Novo Nordisk (NVO +3.51%), a Denmark-based drugmaker, is currentl...
Patients could soon access higher-dose injections. Shares of Novo Nordisk (NVO +3.53%) are gaining on Monday, up 3.5% as of 2:40 p.m. ET. The jump comes as the...
On Wednesday, Novo Nordisk A/S (NYSE:NVO) submitted its supplemental marketing application to the U.S. Food and Drug Administration (FDA) for a higher dose of s...
Novo Nordisk (NVO) stock jumped Wednesday, breathing easily on a lighter-than-feared discount for its semaglutide-based products, Ozempic and Wegovy, under the...
The current maximum Wegovy dose approved for use in the U.S. is a 2.4-milligram injection. Hollie Adams/Reuters Novo Nordisk NOVO.B 4.77 %increase; green up po...
